Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study.
Saved in:
| Title: | Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study. |
|---|---|
| Authors: | Kavanagh, David1,2 (AUTHOR) david.kavanagh@newcastle.ac.uk, Bomback, Andrew S1,3 (AUTHOR), Vivarelli, Marina4 (AUTHOR), Nester, Carla M5 (AUTHOR), Remuzzi, Giuseppe6 (AUTHOR), Zhao, Ming-Hui7 (AUTHOR), Wong, Edwin K S1,2 (AUTHOR), Wang, Yaqin8 (AUTHOR), Krishnan, Induja8 (AUTHOR), Schuhmann, Imelda9 (AUTHOR), Trapani, Angelo J8 (AUTHOR), Webb, Nicholas J A9 (AUTHOR), Meier, Matthias9 (AUTHOR), Israni, Rubeen K8 (AUTHOR), Smith, Richard J H10 (AUTHOR) |
| Source: | Lancet. Oct2025, Vol. 406 Issue 10512, p1587-1598. 12p. |
| Database: | Business Source Ultimate |
| ISSN: | 01406736 |
|---|---|
| DOI: | 10.1016/S0140-6736(25)01148-1 |
